OBIO: orchestrabiomed.com Expected earnings per share growth for next year
Orchestra BioMed (OBIO) is betting on an ESG transformation by minimizing environmental impact during the production of medical technology. The net income per share growth target for the coming year visualizes this trajectory, while the 8.50 metric confirms the current level. The absence of stable cash flows creates risks; however, a strategy of outsourcing production to major partners relieves the company of unnecessary infrastructure expenditures.
Analytical breakdowns for orchestrabiomed.com (OBIO)
- share price and consensus valuation forecast:
- market capitalization information:
- book capitalization information:
- company total debt and liquidity indicators:
Total Debt to Capital Orchestra BioMed|OBIO - Long-Term Debt to Capital Ratio|Short-Term Debt to Capital Orchestra BioMed, Inc.|OBIO - Company Total Debt Obligations|Debts to Book Capitalization Orchestra BioMed|OBIO - Company Long-Term Liabilities|Company Short-Term Debts Orchestra BioMed|Quick Liquidity orchestrabiomed.com
- net income and valuation ratios data:
OBIO - Company Net Income|Future Profit Orchestra BioMed|OBIO - Company Value to Net Income|Forward P/E Multiple Orchestra BioMed|OBIO - Price to Earnings Adjusted for Growth Rate|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Orchestra BioMed|OBIO - Operating profit before depreciation charges|Net earnings per share for the last 12 months Orchestra BioMed|OBIO - Net earnings per share (EPS TTM)|Quarterly EPS earnings growth orchestrabiomed.com|OBIO - Expected net earnings per share growth this year|Net earnings per share growth forecast for next year Orchestra BioMed
- sales volume and revenue indicators:
Initial company analysis:Orchestra BioMed, OBIO
This metric measures the analysts' consensus forecast for the change in earnings per share for the next fiscal year. The history of forward EPS estimates demonstrates market expectations regarding the pace of business scaling. This metric's dynamics react sharply to quarterly reports and adjustments to discounted cash flow models. For Orchestra BioMed (OBIO), this reflects the commercial potential of BackBeat systems and drug-eluting stents in the B2B segment.
Analysis of competing companies
BSX (Boston Scientific Inc) - Earnings growth forecast for next year|Projected earnings per share growth rate for next year EW (Edwards Lifesciences Inc.)|Expected earnings per share growth for next year RMD (ResMed Inc.)|PODD (insulet.com) - Expected earnings per share trend next year|Net earnings per share growth forecast for next year Zimmer Biomet Holdings Inc ZBH|COO - Expected earnings per share growth for next year|Align Technology Inc - Earnings growth forecast for next year|Expected net earnings per share growth next year NuVasive|TMDX: Earnings growth forecast for next year|Projected earnings per share growth rate for next year ATEC|AORT (Artivion) - Earnings growth forecast for next year|Enovis Corp (ENOV) - Consensus forecast of earnings per share growth for next year|Earnings growth forecast for next year IART|Expected earnings per share growth for next year Establishment Labs Inc ESTA|Earnings growth forecast for next year BBNX (Beta Bionics Inc)|Earnings growth forecast for next year iradimed.com IRMD|EMBC - Net earnings per share growth forecast for next year|TNDM: Net earnings per share growth forecast for next year|AXGN (Axogen Corp) - Expected earnings per share growth for next year|SI-BONE Medical - Expected earnings per share trend next year|OFIX (Orthofix Medical Inc.) - Earnings growth forecast for next year|Expected net earnings per share growth next year bioventus.com BVS|Net earnings per share growth forecast for next year OrthoPediatrics Corp. (KIDS)|Treace Medical Concepts Inc (TMCI) - Net earnings per one share growth forecast for next year|Strata Critical Medical Corp - Expected earnings per share growth for next year|Earnings growth forecast for next year Carlsmed Medical CARL|RxSight, Inc. - Earnings growth forecast for next year|Consensus forecast of earnings per share growth for next year ClearPoint Neuro, Inc. CLPT|Stereotaxis (STXS) - Net earnings per share growth forecast for next year|Net earnings per share change forecast for next year STIM (Neuronetics Inc.)|Net earnings per share growth forecast for next year Sight Sciences, Inc|Expected earnings per share growth for next year Anika (ANIK)|Earnings growth forecast for next year NSPR|ZJYL - Expected net earnings per share growth next year|Net earnings per share growth forecast for next year Vivani Medical VANI|XTNT: Projected earnings per share growth rate for next year|NMTC: Expected earnings per share growth for next year|Modular Medical - Projected earnings per share increase next year|Myomo, Inc. (MYO) - Net earnings per share growth forecast for next year|Expected net earnings per share growth next year envoymedical.com (COCH)|Net earnings per share growth forecast for next year Vivos Therapeutics, Inc.|NVNO: Expected earnings per share trend next year|Earnings growth forecast for next year SINT|Expected earnings per share growth for next year Tenon Medical Inc TNON|Earnings growth forecast for next year LFWD (ReWalk Robotics Ltd.)|Expected earnings per share trend next year AMIX|INVO Fertility - Earnings growth forecast for next year|Expected net earnings per share growth next year Bone Biologics Corp.|Axonics Modulation Technologies (AXNX) - Net earnings per share growth forecast for next year|BIOL - Consensus forecast of earnings per share growth for next year|Expected earnings per share growth for next year DYNT|FNA (Paragon 28 Corp) - Projected earnings per share increase next year|Net earnings per share growth forecast for next year INVO Bioscience, Inc. (INVO)
